vs
Side-by-side financial comparison of CoastalSouth Bancshares, Inc. (COSO) and Medirom Healthcare Technologies Inc. (MRM). Click either name above to swap in a different company.
CoastalSouth Bancshares, Inc. is the larger business by last-quarter revenue ($21.3M vs $21.1M, roughly 1.0× Medirom Healthcare Technologies Inc.). CoastalSouth Bancshares, Inc. runs the higher net margin — 31.7% vs -21.3%, a 53.0% gap on every dollar of revenue. Medirom Healthcare Technologies Inc. produced more free cash flow last quarter ($-2.4K vs $-5.9M).
CoastalSouth Bancshares, Inc. is a U.S.-based regional bank holding company. It provides a full range of personal and commercial banking services including deposit accounts, consumer loans, mortgages, commercial financing and wealth management solutions for retail customers and small-to-medium enterprises across the U.S. Gulf Coast region.
Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.
COSO vs MRM — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $21.1M |
| Net Profit | $6.7M | $-4.5M |
| Gross Margin | — | 10.8% |
| Operating Margin | 41.2% | -28.5% |
| Net Margin | 31.7% | -21.3% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.54 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $21.3M | — | ||
| Q2 25 | $19.9M | $21.1M |
| Q3 25 | $6.7M | — | ||
| Q2 25 | $6.0M | $-4.5M |
| Q3 25 | — | — | ||
| Q2 25 | — | 10.8% |
| Q3 25 | 41.2% | — | ||
| Q2 25 | 35.4% | -28.5% |
| Q3 25 | 31.7% | — | ||
| Q2 25 | 30.0% | -21.3% |
| Q3 25 | $0.54 | — | ||
| Q2 25 | $0.57 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $252.3K |
| Total DebtLower is stronger | — | $8.8M |
| Stockholders' EquityBook value | $250.4M | $1.6M |
| Total Assets | $2.3B | $52.0M |
| Debt / EquityLower = less leverage | — | 5.55× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | $252.3K |
| Q3 25 | — | — | ||
| Q2 25 | — | $8.8M |
| Q3 25 | $250.4M | — | ||
| Q2 25 | $209.4M | $1.6M |
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.2B | $52.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | 5.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-2.3K |
| Free Cash FlowOCF − Capex | $-5.9M | $-2.4K |
| FCF MarginFCF / Revenue | -27.7% | -0.0% |
| Capex IntensityCapex / Revenue | 1.9% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.82× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-5.5M | — | ||
| Q2 25 | $-16.8M | $-2.3K |
| Q3 25 | $-5.9M | — | ||
| Q2 25 | $-17.9M | $-2.4K |
| Q3 25 | -27.7% | — | ||
| Q2 25 | -90.3% | -0.0% |
| Q3 25 | 1.9% | — | ||
| Q2 25 | 5.5% | 0.0% |
| Q3 25 | -0.82× | — | ||
| Q2 25 | -2.82× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COSO
Segment breakdown not available.
MRM
| Professional services expense | $20.0M | 95% |
| Other | $1.1M | 5% |
